News Home Page
Access the 15 most recent news items below. For older items, please click the 'view archives' link in the lower right.
Conworx Technology partners with Abbott to Provide Updated Data Management System
Conworx Technology announced the launch of the UniPOC Point-of-Care Data Manager at the 2014 American Association for Clinical Chemistry (AACC) Congress in Chicago. UniPOC is a web-based, vendor neutral platform, offering connectivity to more than 100 POC devices.UniPOC is based on collaboration with Abbott's diabetes care business and is an enhanced version of the widely used PrecisionWeb software.Included in this updated version of the software is a large range of new device interfaces and new ...
Posted on: July 30, 2014
Technical Feasibility Established for MosaiQ CMV and Syphilis Disease Screening Assays
Quotient, a commercial-stage diagnostics company, announced that results generated using the MosaiQ methodology demonstrated a high degree of concordance to predicate technologies screening blood for Cytomegalovirus (CMV) and Syphilis. The feasibility study was conducted in collaboration with FutureDiagnostics Solutions B.V. (Wijchen, The Netherlands) and examined a total of 274 positive and negative samples.The MosaiQ methodology exceeded Quotient's target of concordance levels for both the Syphilis and ...
Posted on: July 30, 2014
Precipio Diagnostics Selects NovoPath APLIS for Complex Hematology-Oncology Testing
Precipio Diagnostics, a hematology-oncology lab, has selected NovoPath anatomic pathology laboratory information system (APLIS) for the management and communication of data to offsite pathologists. Pioneering an innovative laboratory business model, Precipio utilizes remote pathologists at renowned academic institutions to provide high-quality, specialized readings with fast turnaround time."We selected NovoPath because its sophisticated technology can handle extremely complex hematology-oncology ...
Posted on: July 28, 2014
Roche and LifeScan among Leaders in Glucose Monitoring Devices Market in Benelux and Scandinavia, Says GBI Research
The growing market for glucose monitoring devices in Benelux and Scandinavian countries is currently led by Roche, while LifeScan, Bayer and Abbott also hold significant stakes, according to business intelligence provider GBI Research.The company's latest report states that the combined value of the Benelux and Scandinavian glucose monitoring devices markets will increase from $494 million in 2013 to $783 million by 2020, at a compound annual growth rate (CAGR) of 7%. Roche boasts the largest share of any ...
Posted on: July 27, 2014
Nanosphere Signs Molecular Diagnostic Supply Agreement with HealthTrust
Nanosphere, a company enhancing medicine through targeted molecular diagnostics, has announced that it has been selected by HealthTrust as a provider of multi-target molecular diagnostic tests for the nearly1,400 acute care facilities that are part of the HealthTrust membership.Under this agreement, HealthTrust will offer its members access to purchase Nanosphere's portfolio of Verigene multiplex molecular diagnostic infectious disease tests, including those designed to rapidly and accurately detect ...
Posted on: July 25, 2014
CHOP Study: Patients with Specific Gene Variants May Require Higher Doses of Pain-Control Drugs
In the first genome-wide analysis of postsurgical pain in children, pediatric researchers identified variations in genes that affect a child's need for pain-control drugs. The findings suggest that at some point physicians may calibrate pain-medication dosages according to a child's individual genetic makeup."Although this research is only a first step for our team, it provides tremendous new insight into the biological mechanisms and brings us a little closer to personalizing medicine for pain control," ...
Posted on: July 24, 2014
Signal Genetics Obtains New York State Approval for MyPRS Multiple Myeloma Prognostic Test
Signal Genetics Inc. (Signal), a commercial stage, molecular diagnostic company focused on providing innovative diagnostic services that help physicians make better-informed decisions concerning the care of their patients suffering from cancer, today announced New York State Department of Health approval of its MyPRS (Myeloma Prognostic Risk Signature) test."With approval of MyPRS by the New York State Department of Health, we are now available in all 50 U.S. states to provide physicians and ...
Posted on: July 23, 2014
Sebia launches its Hemoglobins Atlas
Sebia, a market leader in protein electrophoresis and tests for the diagnosis of hemoglobin disorders, recently debuted its Hemoglobins Atlas. This tool, which has been developed for the first time, is dedicated to helping Sebia's capillary electrophoresis users orientate their diagnosis of hemoglobinopathies. Hemoglobin electrophoresis is an established technique routinely used in clinical laboratories for screening samples for hemoglobinopathies (hemoglobin variants and thalassemia). ...
Posted on: July 22, 2014
Verigene Enteric Pathogens Test Receives FDA Clearance
Nanosphere Inc., a company enhancing the practice of medicine through targeted molecular diagnostics, announced it has received U.S. FDA 510(k) clearance for the bacterial portion of its Verigene Enteric Pathogens Nucleic Acid Test (EP). Clinical studies for the full panel, including two additional viral targets, have been completed and the Company expects clearance of the full EP panel.Verigene EP is an automated in vitro diagnostic test that simultaneously identifies a broad panel of common ...
Posted on: July 21, 2014
QIAGEN's artus GBS QS-RGQ Kit, Developed with IMDx Obtains CE Marking
The artus GBS QS-RGQ Kit, which is intended as an aid in detecting Group B Streptococcus (GBS) colonization in pregnant women, has obtained CE-marking for use with QIAsymphony SP/AS and Rotor-Gene Q instruments. GBS can be responsible for life-threatening bacterial infections in newborns, making screening of pregnant women important in order to initiate treatment and prevent transmission to newborns. Utilizing the automated workflow of the QIAsymphony SP/AS and Rotor-Gene Q instruments, ...
Posted on: July 20, 2014
Eutropics Laboratory Receives CLIA Certification
Eutropics, a privately held company developing novel diagnostic tests that provide predictive insights to cancer patient response to treatment, recently announced that its clinical diagnostics laboratory, located in Cambridge, Mass., has received CLIA certification from CMS. This certification follows receipt of a Massachusetts State license and allows the company to accept clinical samples from most U.S. states. "With CLIA certification, Eutropics has proven capability in executing complex testing in a ...
Posted on: July 18, 2014
Beckman Coulter to Acquire Siemens Healthcare Diagnostics' Clinical Microbiology Business
Beckman Coulter, an indirect wholly-owned subsidiary of Danaher Corporation, announced yesterday that it has entered into a definitive agreement to purchase the clinical microbiology business of Siemens Healthcare Diagnostics. The Siemens clinical microbiology business is an established leader in microbial identification and antibiotic sensitivity testing (ID/AST). The business operates with an installed base of over 6,000 instruments globally. The microbiology product line includes the MicroScan ...
Posted on: July 17, 2014
Inexpensive Cortisol Testing Developed for Smartphones
Researchers have developed a device that uses any smartphone to measure the cortisol concentration in saliva. The device was presented at ICE/ENDO 2014, the joint meeting of the International Society of Endocrinology and the Endocrine Society in Chicago."We have developed a method for measuring cortisol in saliva using a smartphone and a disposable test strip. This innovation enables anyone with a smartphone to measure their salivary cortisol level quickly, accurately, and affordably," said lead study ...
Posted on: July 16, 2014